Infliximab

Infliximab is a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-alpha), a protein in the body that can cause inflammation. It is a combination medication used to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, and ulcerative colitis. Infliximab works by neutralizing TNF-alpha, thereby reducing the inflammation and alleviating symptoms such as joint pain, swelling, and digestive issues. This medication is typically administered by a healthcare professional through intravenous infusion, and its use should be monitored closely to ensure patient safety and effectiveness.